Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease
Yonatan R. Lewis-Israeli,
Aaron H. Wasserman,
Mitchell A. Gabalski,
Brett D. Volmert,
Yixuan Ming,
Kristen A. Ball,
Weiyang Yang,
Jinyun Zou,
Guangming Ni,
Natalia Pajares,
Xanthippi Chatzistavrou,
Wen Li,
Chao Zhou and
Aitor Aguirre ()
Additional contact information
Yonatan R. Lewis-Israeli: Michigan State University
Aaron H. Wasserman: Michigan State University
Mitchell A. Gabalski: Michigan State University
Brett D. Volmert: Michigan State University
Yixuan Ming: Washington University in Saint Louis
Kristen A. Ball: Michigan State University
Weiyang Yang: Michigan State University
Jinyun Zou: Washington University in Saint Louis
Guangming Ni: Washington University in Saint Louis
Natalia Pajares: Michigan State University
Xanthippi Chatzistavrou: Michigan State University
Wen Li: Michigan State University
Chao Zhou: Washington University in Saint Louis
Aitor Aguirre: Michigan State University
Nature Communications, 2021, vol. 12, issue 1, 1-16
Abstract:
Abstract Congenital heart defects constitute the most common human birth defect, however understanding of how these disorders originate is limited by our ability to model the human heart accurately in vitro. Here we report a method to generate developmentally relevant human heart organoids by self-assembly using human pluripotent stem cells. Our procedure is fully defined, efficient, reproducible, and compatible with high-content approaches. Organoids are generated through a three-step Wnt signaling modulation strategy using chemical inhibitors and growth factors. Heart organoids are comparable to age-matched human fetal cardiac tissues at the transcriptomic, structural, and cellular level. They develop sophisticated internal chambers with well-organized multi-lineage cardiac cell types, recapitulate heart field formation and atrioventricular specification, develop a complex vasculature, and exhibit robust functional activity. We also show that our organoid platform can recreate complex metabolic disorders associated with congenital heart defects, as demonstrated by an in vitro model of pregestational diabetes-induced congenital heart defects.
Date: 2021
References: Add references at CitEc
Citations: View citations in EconPapers (6)
Downloads: (external link)
https://www.nature.com/articles/s41467-021-25329-5 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25329-5
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-021-25329-5
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().